Successful Desensitization with Crizotinib after Crizotinib-induced Liver Injury in ROS1-rearranged Lung Adenocarcinoma

Crizotinib has been approved for patients with advanced lung adenocarcinoma harboring rearrangements of the c-ROS-1 (ROS1) and anaplastic lymphoma kinase (ALK) genes. We report a patient with ROS1-rearranged lung adenocarcinoma who developed a crizotinib-induced mixed/cholestatic type of liver injur...

Descripción completa

Detalles Bibliográficos
Autores principales: Ota, Takayo, Masuda, Noriyuki, Matsui, Kaoru, Yamada, Takao, Tanaka, Noriko, Fujimoto, Shunsuke, Fukuoka, Masahiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6794186/
https://www.ncbi.nlm.nih.gov/pubmed/31178493
http://dx.doi.org/10.2169/internalmedicine.2554-18

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6794186/
https://www.ncbi.nlm.nih.gov/pubmed/31178493
http://dx.doi.org/10.2169/internalmedicine.2554-18

Ejemplares similares